资讯

PMLive17 小时
Ipsen’s elafibranor shows promise in rare liver disease primary sclerosing cholangitis
Ipsen’s elafibranor has shown promise as a treatment for primary sclerosing cholangitis (PSC), a rare liver disease that ...